Dr. Andreas Behren
Honorary
Medicine - Austin Health
58 Scholarly works
1 Projects
HIGHLIGHTS
2020
Journal article
Spliced Peptides and Cytokine-Driven Changes in the Immunopeptidome of Melanoma
DOI: 10.1158/2326-6066.CIR-19-08942020
Journal article
Evaluation of Combination Nivolumab and Ipilimumab Immunotherapy in Patients With Advanced Biliary Tract Cancers Subgroup Analysis of a Phase 2 Nonrandomized Clinical Trial
DOI: 10.1001/jamaoncol.2020.28142020
Journal article
Methylation dependent gold adsorption behaviour identifies cancer derived extracellular vesicular DNA
DOI: 10.1039/d0nh00258e2020
Journal article
Aberrant pregnancy-associated plasma protein-A expression in breast cancers prognosticates clinical outcomes
DOI: 10.1038/s41598-020-70774-92020
Conference Proceedings
Butyrophilin molecules govern gamma delta T cell reactivity against phosphoantigens
2020
Research Grant
RECOGNITION OF PHOSPHOANTIGEN BY GAMMA-DELTA T CELLS
2013
Journal article
BRAF/NRAS Wild-Type Melanomas Have a High Mutation Load Correlating with Histologic and Molecular Signatures of UV Damage
DOI: 10.1158/1078-0432.CCR-13-0398
RECENT SCHOLARLY WORKS
2020
Journal article
A Distinct Pretreatment Immune Gene Signature in Lentigo Maligna Is Associated with Imiquimod Response
DOI: 10.1016/j.jid.2019.07.7252020
Journal article
Butyrophilin 2A1 is essential for phosphoantigen reactivity by gamma delta T cells
DOI: 10.1126/science.aay55162020
Journal article
Pan-cancer analysis of whole genomes
DOI: 10.1038/s41586-020-1969-62020
Journal article
Tracking extracellular vesicle phenotypic changes enables treatment monitoring in melanoma
DOI: 10.1126/sciadv.aax32232020
Journal article
Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma
DOI: 10.1136/jitc-2019-0004102020
Journal article
A First-in-Human Dose Finding Study of Camrelizumab in Patients with Advanced or Metastatic Cancer in Australia
DOI: 10.2147/DDDT.S2437872019
Journal article
A Gene Signature Predicting Natural Killer Cell Infiltration and Improved Survival in Melanoma Patients
DOI: 10.1158/2326-6066.CIR-18-05002019
Conference Proceedings
A phase II clinical trial of ipilimumab/nivolumab combination immunotherapy in patients with rare upper gastrointestinal, neuroendocrine, and gynecological malignancies.
DOI: 10.1200/JCO.2019.37.15_suppl.2570